GetTopicDetailResponse(id=68f6315e6a4, topicName=分子分類, introduction=分子分類, content=null, image=null, comments=3, allHits=1259, url=https://h5.medsci.cn/topic?id=31576, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=65042, tagList=[TagDto(tagId=65042, tagName=分子分類)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2254235, encodeId=81f12254235d4, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宮內(nèi)膜癌#</a> <a href='/topic/show?id=68f6315e6a4' target=_blank style='color:#2F92EE;'>#分子分類#</a>, objectTitle=子宮內(nèi)膜癌混合性癌大隊(duì)列：分子分型預(yù)測(cè)復(fù)發(fā)實(shí)力碾壓形態(tài)學(xué)，HER2靶藥迎契機(jī), objectType=article, longId=865162, objectId=48fc865162b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing.jpg, objectUrl=/article/show_article.do?id=48fc865162b1, replyNumber=0, likeNumber=43, createdTime=2025-03-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=48fc865162b1, moduleTitle=子宮內(nèi)膜癌混合性癌大隊(duì)列：分子分型預(yù)測(cè)復(fù)發(fā)實(shí)力碾壓形態(tài)學(xué)，HER2靶藥迎契機(jī), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=48fc865162b1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2027660, encodeId=7788202e660b1, content=<a href='/topic/show?id=68f6315e6a4' target=_blank style='color:#2F92EE;'>#分子分類#</a>, objectTitle=Blood：分子分類可改善BCR-ABL1陰性B-ALL成人患者的風(fēng)險(xiǎn)評(píng)估, objectType=article, longId=217625, objectId=ef7421e625f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef7421e625f6, replyNumber=0, likeNumber=77, createdTime=2022-04-29, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef7421e625f6, moduleTitle=Blood：分子分類可改善BCR-ABL1陰性B-ALL成人患者的風(fēng)險(xiǎn)評(píng)估, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ef7421e625f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027659, encodeId=f4a0202e659f6, content=<a href='/topic/show?id=68f6315e6a4' target=_blank style='color:#2F92EE;'>#分子分類#</a>, objectTitle=Blood：可通過石蠟切片鑒別原發(fā)性縱膈大B細(xì)胞淋巴瘤的分子分類方法, objectType=article, longId=149771, objectId=d9d1149e71c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9d1149e71c5, replyNumber=0, likeNumber=105, createdTime=2018-11-28, rootId=0, userName=柳葉一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9d1149e71c5, moduleTitle=Blood：可通過石蠟切片鑒別原發(fā)性縱膈大B細(xì)胞淋巴瘤的分子分類方法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d9d1149e71c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027658, encodeId=fccd202e6582a, content=<a href='/topic/show?id=68f6315e6a4' target=_blank style='color:#2F92EE;'>#分子分類#</a>, objectTitle=CLIN CANCER RES：1q32.1擴(kuò)增為子宮內(nèi)膜癌分子分類提供信息, objectType=article, longId=122623, objectId=d1d612262310, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d612262310, replyNumber=0, likeNumber=85, createdTime=2018-06-09, rootId=0, userName=柳葉一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d612262310, moduleTitle=CLIN CANCER RES：1q32.1擴(kuò)增為子宮內(nèi)膜癌分子分類提供信息, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d1d612262310)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
